Company: LCTX
Filing Date: 2025-01-27
Form Type: 8-K
Source: 0000950170-25-009227
Chunk: 4

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-01-27
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
          4.1      Warrant issued to Broadwood Partners, L. P. on January 27, 2025              
         99.1      Press release issued on January 27, 2025                                     
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                               Lineage Cell Therapeutics, Inc.          
  Date:      January 27, 2025      By:         /s/ George A. Samuel III                 
                                   Name:       George A. Samuel III